Effects of mTOR Inhibition on Muscle Health in Older Adults
Official title: Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle.
Run by University of Nottingham · NCT05414292 · Data updated 2026-11-12
This study is testing if a medication called Rapamune can help older adults with muscle loss get stronger when they do resistance exercises.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 90 Years |
| Sex | Men only |
| Enrollment | 16 (estimated) |
| Sponsor | University of Nottingham Academic / other |
| Locations | 1 site (Derby) |
| Status | Recruiting |
| Started | August 6, 2021 |
| Main results expected | May 1, 2027 |
| Study ends | May 1, 2027 |
| Registry record updated | April 10, 2025 |
| Trial ID | NCT05414292 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are older adults who are physically able to participate in resistance exercise training and are experiencing muscle atrophy or sarcopenia.
✕Probably not a fit
Patients with significant cardiovascular, respiratory, or metabolic diseases, or those with a BMI outside the specified range, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of inhibiting the mechanistic target of rapamycin (mTOR) on muscle health in older adults experiencing muscle atrophy and age-related sarcopenia. Participants will undergo unilateral resistance exercise training while receiving Rapamune (sirolimus) to assess its impact on muscle protein synthesis and overall muscle function. The study aims to explore whether mTOR inhibition can enhance muscle responses to exercise in individuals who may not be able to engage in regular physical activity. By understanding the role of mTOR in muscle maintenance, the research seeks to identify potential therapeutic strategies for combating age-related muscle loss.
Why it matters
Potential benefit: If successful, this study could provide a new pharmacological approach to improve muscle mass and function in older adults, enhancing their quality of life and independence.
How similar studies have gone: While the approach of mTOR inhibition has shown promise in animal studies, this specific application in humans is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study * Participant is physically able to complete the resistance exercise training programme Exclusion Criteria: * • A BMI \<18 or \>35 kg/m2 * Active cardiovascular, cerebrovascular or respiratory disease: e.g. uncontrolled hypertension (BP \> 160/100), angina, heart failure (class III/IV), arrhythmia, right to left cardiac shunt, recent cardiac event, COPD, pulmonary hypertension or recent stroke * Any metabolic disease * Clotting dysfunction * A history of, or current neurological or musculoskeletal conditions (e.g. epilepsy) * Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance (this must remain for ALL UoN FMHS UREC approved studies) * Contraindications to MRI scanning including claustrophobia, pacemaker, metal implants etc. which will be assessed through an MRI safety screening questionnaire. * Contraindications to the use of Rapamycin e.g. those due scheduled vaccinations (as rapamycin can reduce the efficacy of vaccines).
Where it's running
-
University of Nottingham School of Medicine
Derby, United Kingdom Recruiting
Study contacts
- Study coordinator: Philip Atherton, PhD
- Email: philip.atherton@nottingham.ac.uk
- Phone: 01332724725
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Protein boost during the luteal phase to help protect muscle
This study tests whether increasing daily protein intake by 12% during the luteal phase can help prevent muscle breakdown in premenopausal women aged 18–35.
-
Postoperative NMES on both thighs with protein during abdominal cancer surgery
This study tests whether neuromuscular electrical stimulation of both thighs after major abdominal cancer surgery helps preserve leg muscle, and whether adding protein drinks improves the effect.
-
Effects of changing physical activity levels on health in middle-aged adults
This study tests how changing physical activity levels—either cutting back or increasing exercise—affects health in middle-aged adults, especially looking at issues like metabolic syndrome and cognitive decline.
-
Assessing muscle thickness changes in heart failure patients
This study is testing how muscle thickness changes in heart failure patients receiving advanced treatments like heart transplants or assist devices to see how it affects their recovery.
-
Essential amino acid supplementation for patients with femoral fractures
This study is testing if taking essential amino acids for four weeks after surgery can help people with femoral fractures recover better and keep their muscle strength.
-
Combining muscle activation and high-protein nutrition to improve muscle health in ICU patients
This study is testing if giving high-protein nutrition along with muscle activation exercises can help critically ill patients in the ICU keep their muscles strong and recover better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.